Molecules of Korolchuk IP-NFT (VITA-FAST) Price Prediction 2026–2050

VITA-FAST is an ERC-20 token that represents fractional ownership of the IP-NFT from longevity research conducted at the Korolchuk Lab, Newcastle University. Token holders gain governance rights over the IP, enabling democratic decision-making in scientific research.

The project centers on discovering and developing therapeutic compounds that can reactivate autophagy in NPC1 -/- cells. It uses high-throughput screening and advanced assays such as luciferase-p6 clearance and Halo-GFP-LC3 orthogonal assays to identify potential autophagy activators that are not cytotoxic.

Led by Dr. Korolchuk and his team at Newcastle University, the initiative has progressed from generating data on thousands of compounds to identifying lead compounds and moving toward pharmacokinetics and scalability studies, with plans to screen third-generation compounds and conduct in vitro and in vivo models using patient data.

Molecules of Korolchuk IP-NFT, trading under the symbol VITA-FAST, is the asset at the center of this analysis. It currently price sits at $0.774 with a market cap of $774.04K and a rank of 3067. The all-time high and all-time low are $31.21 and $0.6642, respectively, framing a broad historical range.

The forecast suggests a cautious near-term path with modest movement through 2026-2029, followed by stronger long-term potential. In 2027 the average price is projected to $1.38 with a 78.5% ROI, and in 2028 it is $1.43 with an 84.9% ROI. By 2040 the average is projected to $2.14 (ROI 176.5%), and by 2050 an average of $3.75 (ROI 384.8%), indicating meaningful upside over the longer horizon.

These are estimates and not guarantees. The asset’s price trajectory reflects a mix of near-term stability and longer-term upside, framed by a broad historical range between its all-time high and low.

The multi-year forecast spans 2026 through 2050, showing a generally bullish trajectory in the longer term despite near-term pauses. In 2026 the min/avg/max are $0.6901 / $0.774 / $0.985 with a 0% ROI, signaling a flat start. By 2027 the average rises to $1.38 (ROI 78.5) and by 2028 to $1.43 (ROI 84.9), sustaining a bullish tone.

In 2030 the forecast turns softer, with an average of $0.6973 and a min of $0.4194 and a max of $1.24, and a negative ROI of -9.9. The period then resumes growth: 2031 average $1.60 (ROI 106.8) and 2032 average $1.53 (ROI 97.1). Some years show neutral or modest moves (2033 avg $0.9046, ROI 16.9).

From 2034 onward the outlook improves markedly, with 2034 avg $1.32 (ROI 70.6) and 2035 avg $1.89 (ROI 143.8). The long horizon strengthens further, with 2040 avg $2.14 (ROI 176.5) and 2050 avg $3.75 (ROI 384.8), both labeled bullish. These projections imply meaningful upside over the coming decades, albeit with notable volatility and non-guaranteed outcomes.